Ozempic is traditionally used as a treatment for type 2 diabetes (T2DM) to help patients manage blood sugar levels. However, ...

The remarkable efficacy of new diabetes and weight loss medicines like Ozempic and Mounjaro have been one of the biggest health stories of recent years. Despite rising rates of diabetes and obesity, ...

Nearly 2 in 3 people without diabetes quit popular weight loss drugs such as Ozempic or Victoza within one year, according to ...

Novo Nordisk's 2024 earnings exceeded estimates, with strong performance in diabetes, obesity, and rare disease segments.

The governing board of the State Health Plan is expected to give state treasurer Brad Briner the go-ahead Friday to overhaul ...

STRUGGLING to keep up with her two young children and dreading her own reflection in the mirror, Emma Lasenby knew something ...

Taking a compounded GLP-1 medication isn’t the same thing as your pharmacy filling a cheaper, generic version of the drug ...

Welcome to the full-year 2024 Novo Nordisk earnings conference call. [Operator instructions] Please be advised that today's conference is being recorded. I would now like to hand the conference over ...

Additionally, some medications used for obesity and diabetes, such as glucagon-like receptor 1 (GLP-1) agonists like Trulicity (dulaglutide), or Saxenda (liraglutide ... you find a plan that enables ...

WEIGHT-loss jabs are taking the world by storm, with a staggering half a million of us now using them. The injections have ...

A clinical trial has backed the safety and efficacy of one of Novo Nordisk's weight-loss medicines in children ... company's older GLP-1 agonist therapy Saxenda (liraglutide), which requires ...

The institute will offer weight-loss and obesity services and procedures. Here's where it will be built and when it will be completed. Orlando Health shared plans for its new Weight Loss and ...